107 - Robotics In Interventional Neuroendovascular Therapies: A Systematic Review

Purpose: To discuss the feasibility and current problems in Interventional Neuroendovascular Therapies where robots can help along with their challenges and benefits.

Material and Methods: A comprehensive literature search of PubMed, Ovid MEDLINE, and Ovid Embase was performed for studies published from 2000 to October 2022. The search used the following keywords: “Humans,” “Nervous System Diseases / diagnostic imaging*,” “Nervous System Diseases / surgery,” “Radiography, Interventional / methods*,” “Robotics / methods*,” “Stroke / diagnostic imaging,” “Stroke / surgery; Telemedicine,” and “Thrombectomy” in both “AND” and “OR” combinations. The inclusion criteria are the studies that reported the use of Food and Drug Administration (FDA) approved robotic navigation platforms in interventional radiology. The search strategy was confined to English language.

Results: Commercially available systems such as the Sensei and Magellan robotic catheter systems (Auris Surgical Robotics), Amigo remote catheter system (Catheter Precision Inc), and CorPath vascular robotic system (Corindus Vascular Robotics) are electromechanically operated, and the Niobe magnetic navigation system (Stereotaxis USA) is magnetically controlled. Further, the feasibility of these systems, strengths, weakness of these systems and challenges faced are discussed in detail.

Conclusions: The preliminary data from these studies are promising for the future of robots in Interventional Neuroendovascular Therapies. However, multicenter prospective studies are required to improve patient outcomes.